dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2020-12-10T20:11:11Z
dc.date.accessioned2022-12-19T20:26:48Z
dc.date.available2020-12-10T20:11:11Z
dc.date.available2022-12-19T20:26:48Z
dc.date.created2020-12-10T20:11:11Z
dc.date.issued2019-10-05
dc.identifierToxicon. Oxford: Pergamon-elsevier Science Ltd, v. 168, p. S5-S6, 2019.
dc.identifier0041-0101
dc.identifierhttp://hdl.handle.net/11449/197260
dc.identifier10.1016/j.toxicon.2019.06.042
dc.identifierWOS:000565210200019
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5377898
dc.languageeng
dc.publisherElsevier B.V.
dc.relationToxicon
dc.sourceWeb of Science
dc.titlePROSPECTING, DEVELOPMENT, OPTIMIZATION AND CLINICAL TRIAL OF NEW ANTIAPILIC ANTIVENOM
dc.typeOtros


Este ítem pertenece a la siguiente institución